PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1998; 91(Suppl 34): 14–18.
PMCID: PMC1296368

Osteoporosis in adults with cystic fibrosis.

Abstract

Osteoporosis is prevalent in adults with CF Longitudinal data have not been collected and so the natural history is unknown. The aetiology is not known. There are no published randomized controlled trials evaluating treatments for osteoporosis in CF patients.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1023K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Stamp TC, Geddes DM. Osteoporosis and cystic fibrosis. Thorax. 1993 Jun;48(6):585–586. [PMC free article] [PubMed]
  • Greenfield EM, Goldberg VM. Genetic determination of bone density. Lancet. 1997 Nov 1;350(9087):1263–1264. [PubMed]
  • Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC., Jr Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res. 1991 Jun;6(6):561–567. [PubMed]
  • Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature. 1994 Jan 20;367(6460):284–287. [PubMed]
  • Weisman Y, Reiter E, Stern RC, Root A. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with cystic fibrosis. J Pediatr. 1979 Sep;95(3):416–418. [PubMed]
  • Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. 1979 Jan;94(1):38–42. [PubMed]
  • Slemenda CW, Miller JZ, Hui SL, Reister TK, Johnston CC., Jr Role of physical activity in the development of skeletal mass in children. J Bone Miner Res. 1991 Nov;6(11):1227–1233. [PubMed]
  • Ruiz JC, Mandel C, Garabedian M. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents. J Bone Miner Res. 1995 May;10(5):675–682. [PubMed]
  • Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA. 1992 Nov 4;268(17):2403–2408. [PubMed]
  • Snow-Harter C, Bouxsein ML, Lewis BT, Carter DR, Marcus R. Effects of resistance and endurance exercise on bone mineral status of young women: a randomized exercise intervention trial. J Bone Miner Res. 1992 Jul;7(7):761–769. [PubMed]
  • Friedlander AL, Genant HK, Sadowsky S, Byl NN, Glüer CC. A two-year program of aerobics and weight training enhances bone mineral density of young women. J Bone Miner Res. 1995 Apr;10(4):574–585. [PubMed]
  • Bilton D, Dodd ME, Abbot JV, Webb AK. The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis. Respir Med. 1992 Nov;86(6):507–511. [PubMed]
  • O'Neill PA, Dodds M, Phillips B, Poole J, Webb AK. Regular exercise and reduction of breathlessness in patients with cystic fibrosis. Br J Dis Chest. 1987 Jan;81(1):62–69. [PubMed]
  • Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992 Feb 27;326(9):600–604. [PubMed]
  • Reiter EO, Stern RC, Root AW. The reproductive endocrine system in cystic fibrosis. I. Basal gonadotropin and sex steroid levels. Am J Dis Child. 1981 May;135(5):422–426. [PubMed]
  • Landon C, Rosenfeld RG. Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment. Am J Dis Child. 1984 Apr;138(4):388–391. [PubMed]
  • Bhudhikanok GS, Lim J, Marcus R, Harkins A, Moss RB, Bachrach LK. Correlates of osteopenia in patients with cystic fibrosis. Pediatrics. 1996 Jan;97(1):103–111. [PubMed]
  • Grey AB, Ames RW, Matthews RD, Reid IR. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax. 1993 Jun;48(6):589–593. [PMC free article] [PubMed]
  • Bachrach LK, Loutit CW, Moss RB. Osteopenia in adults with cystic fibrosis. Am J Med. 1994 Jan;96(1):27–34. [PubMed]
  • Gibbens DT, Gilsanz V, Boechat MI, Dufer D, Carlson ME, Wang CI. Osteoporosis in cystic fibrosis. J Pediatr. 1988 Aug;113(2):295–300. [PubMed]
  • Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr. 1996 Jan;128(1):28–34. [PubMed]
  • Shaw N, Bedford C, Heaf D, Carty H, Dutton J. Osteopenia in adults with cystic fibrosis. Am J Med. 1995 Dec;99(6):690–692. [PubMed]
  • Henderson RC, Specter BB. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr. 1994 Aug;125(2):208–212. [PubMed]
  • Ross J, Gamble J, Schultz A, Lewiston N. Back pain and spinal deformity in cystic fibrosis. Am J Dis Child. 1987 Dec;141(12):1313–1316. [PubMed]
  • Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D. Severe osteoporosis before and after lung transplantation. Chest. 1996 May;109(5):1176–1183. [PubMed]
  • Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 1996 Sep;101(3):262–269. [PubMed]
  • Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Jr, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995 Nov 30;333(22):1437–1443. [PubMed]
  • Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, 3rd, Yanover MJ, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990 Jul 12;323(2):73–79. [PubMed]
  • Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet. 1988 Jan 23;1(8578):143–146. [PubMed]
  • Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997 Aug 7;337(6):382–387. [PubMed]
  • Baroncelli GI, De Luca F, Magazzú G, Arrigo T, Sferlazzas C, Catena C, Bertelloni S, Saggese G. Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res. 1997 Mar;41(3):397–403. [PubMed]
  • Gallacher SJ, Fenner JA, Anderson K, Bryden FM, Banham SW, Logue FC, Cowan RA, Boyle IT. Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study. Thorax. 1992 Nov;47(11):932–936. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press